Textbook Chapters
Journal Articles
Additional Journal Articles
Requests for copies of recent publications can be made at ibtpp@infantbotulism.org
- Descriptive epidemiology of infant botulism in California: the first 40 years. Panditrao MV, Dabritz HA, Kazerouni N, Meissinger JK, Arnon SS. 2020.. J Pediatr 227: 247-257.
- Seven-year case-control study in California of risk factors for infant botulism. Panditrao MV, Dabritz HA, Kazerouni N, Damus K, Meissinger JK, Arnon SS. 2020. J Pediatr 227:258-267.
- Dual-toxin ("bivalent") infant botulism in California, 1976-2020: epidemiological, clinical and laboratory aspects. Pandiatrao MV, Chung CH, Khouri JM, Barash JR, Motter RN, Dover N, Arnon SS. Dual-toxin ("bivalent") infant botulism in California, 1976-2020: epidemiological, clinical and laboratory aspects. J Pediatr S0022-3476:00725-00729.
- Molecular characterization of a novel botulinum neurotoxin type H gene. Dover N, Barash JR, Hill KK, Xie G, Arnon SS. 2014. J Infect Dis 209(2):192-202.
- Closed genome sequence of Clostridium botulinum strain IBCA10-7060 type Bh. Dover N, Barash JR, Bell JM, Sylvester MD, Arnon SS. 2021. Microb Resour Announc 10(34):30038321.
- Duration of fecal excretion of Clostridium Botulinum and Botulinum Neurotoxin in Patients Recovering from infant Botulism. Dabritz HA, Payne JR, Khouri JM. J. 2023 Pediatr: Online ahead of print: 113396
Official State of California Department of Public Health website
|